SCHEMBL174817

SCHEMBL174817

CCCNC(=O)Oc1ccccc1OCCc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.49
RAB9A P51151 4/20 0.49
TAAR1 Q96RJ0 2/20 0.49
GAA P10253 1/20 0.49
SIGMAR1 Q99720 2/20 0.46
PTGES O14684 3/20 0.46
ALOX5 P09917 3/20 0.46
PPARG P37231 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.45
MAPT P10636 1/20 0.45
NFKB1 P19838 1/20 0.45
NFKB2 Q00653 1/20 0.45
RELA Q04206 1/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
FAAH O00519 1/20 0.44
MTNR1A P48039 1/20 0.44
MTNR1B P49286 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL174818 0.84 NPC1 (0.63) NPC1RAB9ATAAR1GAASMN1; SMN2
SCHEMBL4435233 0.81 KMT2A (0.62) GAAMAPTKMT2A
SCHEMBL25272434 0.75 MGLL (0.49) GAASMN1; SMN2MAPTMEN1KMT2A
SCHEMBL25272667 0.75 NCEH1 (0.47) GAAMAPTMEN1KMT2AMTNR1A
SCHEMBL15339806 0.75 CES2 (0.52) NPC1RAB9ATAAR1GAASMN1; SMN2
SCHEMBL8208860 0.74 KMT2A (0.53) NPC1RAB9AGAAPTGESALOX5
SCHEMBL11300929 0.74 MEN1 (0.50) NPC1RAB9AGAAMAPTMEN1
SCHEMBL2725992 0.74 CES2 (0.51) NPC1RAB9ATAAR1GAASMN1; SMN2
SCHEMBL17912813 0.73 CYP11B1 (0.56) NPC1RAB9AGAASMN1; SMN2MAPT
SCHEMBL15334134 0.73 NPC1 (0.66) NPC1RAB9ATAAR1GAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424842-A2 DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE Aerie Pharmaceuticals, Inc. (US) 2012-03-07 EP disclosed
WO-2010126626-A2 DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE AERIE PHARMACEUTICALS, INC. (US) 2010-11-04 WO disclosed